Kanger to receive 10,000 doses of Sinopharm Covid-19 vaccine in May for trial purposes
KUALA LUMPUR (March 9): Kanger International Bhd will receive 10,000 doses of a Covid-19 vaccine developed by state-owned China National Pharmaceutical Group Corp (Sinopharm) for trial purposes.